Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-023720

PRESIDENT AND CEO sold 60,000 shares at an average $74.08 ($4,444,626)

  • PRESIDENT AND CEO acquired 60,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Torley Helen PRESIDENT AND CEO 2025-09-02 Option exercise 10b5-1 +20,000 $8.11 $162,200 753,719 D
Torley Helen PRESIDENT AND CEO 2025-09-02 Sale 10b5-1 −300 $72.49 $21,746 753,419 D
Torley Helen PRESIDENT AND CEO 2025-09-02 Sale 10b5-1 −16,288 $73.70 $1,200,393 737,131 D
Torley Helen PRESIDENT AND CEO 2025-09-02 Sale 10b5-1 −3,412 $74.15 $252,990 733,719 D
Torley Helen PRESIDENT AND CEO 2025-09-03 Option exercise 10b5-1 +20,000 $8.11 $162,200 753,719 D
Torley Helen PRESIDENT AND CEO 2025-09-03 Sale 10b5-1 −9,500 $74.22 $705,090 744,219 D
Torley Helen PRESIDENT AND CEO 2025-09-03 Sale 10b5-1 −10,500 $74.63 $783,636 733,719 D
Torley Helen PRESIDENT AND CEO 2025-09-04 Option exercise 10b5-1 +20,000 $8.11 $162,200 753,719 D
Torley Helen PRESIDENT AND CEO 2025-09-04 Sale 10b5-1 −9,900 $73.54 $728,006 743,819 D
Torley Helen PRESIDENT AND CEO 2025-09-04 Sale 10b5-1 −7,800 $74.33 $579,751 736,019 D
Torley Helen PRESIDENT AND CEO 2025-09-04 Sale 10b5-1 −2,300 $75.22 $173,015 733,719 D
Derivatives
Torley Helen PRESIDENT AND CEO 2025-09-02 Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $8.11 $162,200 176,569 D
Torley Helen PRESIDENT AND CEO 2025-09-03 Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $8.11 $162,200 156,569 D
Torley Helen PRESIDENT AND CEO 2025-09-04 Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $8.11 $162,200 136,569 D
Open-market sales · 60,000 sh · avg $74.08 · $4,444,626
Loading xslF345X05/form4-09042025_090922.xml…